Loading...

Kancelaria Medius

WSE:KME
Snowflake Description

Mediocre balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
KME
WSE
PLN133M
Market Cap
  1. Home
  2. PL
  3. Commercial Services
Company description

Kancelaria Medius S.A. engages in the receivables management business in Poland. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
KME Share Price and Events
7 Day Returns
-1.1%
WSE:KME
3.9%
PL Commercial Services
1.6%
PL Market
1 Year Returns
-64%
WSE:KME
-17.5%
PL Commercial Services
-1.8%
PL Market
KME Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Kancelaria Medius (KME) -1.1% -2.2% -8.1% -64% 127.5% 1650%
PL Commercial Services 3.9% 0.2% 6.4% -17.5% -2.7% 9.2%
PL Market 1.6% 1% 3% -1.8% 12.8% -2.4%
1 Year Return vs Industry and Market
  • KME underperformed the Commercial Services industry which returned -17.5% over the past year.
  • KME underperformed the Market in Poland which returned -1.8% over the past year.
Price Volatility
KME
Industry
5yr Volatility vs Market

KME Value

 Is Kancelaria Medius undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Kancelaria Medius. This is due to cash flow or dividend data being unavailable. The share price is PLN9.1.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Kancelaria Medius's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Kancelaria Medius's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WSE:KME PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in PLN PLN1.51
WSE:KME Share Price ** WSE (2019-03-20) in PLN PLN9.1
Poland Commercial Services Industry PE Ratio Median Figure of 23 Publicly-Listed Commercial Services Companies 9.5x
Poland Market PE Ratio Median Figure of 466 Publicly-Listed Companies 10.81x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Kancelaria Medius.

WSE:KME PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= WSE:KME Share Price ÷ EPS (both in PLN)

= 9.1 ÷ 1.51

6.03x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Kancelaria Medius is good value based on earnings compared to the PL Commercial Services industry average.
  • Kancelaria Medius is good value based on earnings compared to the Poland market.
Price based on expected Growth
Does Kancelaria Medius's expected growth come at a high price?
Raw Data
WSE:KME PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 6.03x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
-5.3%per year
Europe Commercial Services Industry PEG Ratio Median Figure of 55 Publicly-Listed Commercial Services Companies 1.34x
Poland Market PEG Ratio Median Figure of 105 Publicly-Listed Companies 1.14x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Kancelaria Medius, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Kancelaria Medius's assets?
Raw Data
WSE:KME PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in PLN PLN4.33
WSE:KME Share Price * WSE (2019-03-20) in PLN PLN9.1
Poland Commercial Services Industry PB Ratio Median Figure of 26 Publicly-Listed Commercial Services Companies 1.02x
Poland Market PB Ratio Median Figure of 690 Publicly-Listed Companies 1x
WSE:KME PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= WSE:KME Share Price ÷ Book Value per Share (both in PLN)

= 9.1 ÷ 4.33

2.1x

* Primary Listing of Kancelaria Medius.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Kancelaria Medius is overvalued based on assets compared to the PL Commercial Services industry average.
X
Value checks
We assess Kancelaria Medius's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Commercial Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Commercial Services industry average (and greater than 0)? (1 check)
  5. Kancelaria Medius has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

KME Future Performance

 How is Kancelaria Medius expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Kancelaria Medius, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-5.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Kancelaria Medius expected to grow at an attractive rate?
  • Kancelaria Medius's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.9%.
Growth vs Market Checks
  • Kancelaria Medius's earnings are expected to decrease over the next 1-3 years, this is below the Poland market average.
  • Unable to compare Kancelaria Medius's revenue growth to the Poland market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
WSE:KME Future Growth Rates Data Sources
Data Point Source Value (per year)
WSE:KME Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts -5.3%
Poland Commercial Services Industry Earnings Growth Rate Market Cap Weighted Average 6.6%
Europe Commercial Services Industry Revenue Growth Rate Market Cap Weighted Average 4.6%
Poland Market Earnings Growth Rate Market Cap Weighted Average 10.6%
Poland Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WSE:KME Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in PLN Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WSE:KME Past Financials Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income *
2018-12-31 49 -18 22
2018-09-30 67 -31 21
2018-06-30 68 -47 25
2018-03-31 59 -34 18
2017-12-31 53 -24 16
2017-09-30 32 -43 15
2017-06-30 27 -19 11
2017-03-31 32 -22 13
2016-12-31 29 -16 8
2016-09-30 23 2 6
2016-06-30 20 -9 5
2016-03-31 17 -5 4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Kancelaria Medius's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Unable to determine if Kancelaria Medius is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WSE:KME Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Kancelaria Medius Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:KME Past Financials Data
Date (Data in PLN Millions) EPS *
2018-12-31 1.51
2018-09-30 1.46
2018-06-30 1.71
2018-03-31 1.23
2017-12-31 1.13
2017-09-30 1.00
2017-06-30 0.73
2017-03-31 0.87
2016-12-31 0.56
2016-09-30 0.57
2016-06-30 0.43
2016-03-31 0.48

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Kancelaria Medius will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Kancelaria Medius's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Poland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Kancelaria Medius has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

KME Past Performance

  How has Kancelaria Medius performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Kancelaria Medius's growth in the last year to its industry (Commercial Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Kancelaria Medius has delivered over 20% year on year earnings growth in the past 5 years.
  • Kancelaria Medius's 1-year earnings growth is less than its 5-year average (34.4% vs 55.3%)
  • Kancelaria Medius's earnings growth has not exceeded the PL Commercial Services industry average in the past year (34.4% vs 48.9%).
Earnings and Revenue History
Kancelaria Medius's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Kancelaria Medius Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:KME Past Revenue, Cash Flow and Net Income Data
Date (Data in PLN Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 49.31 22.09 5.74
2018-09-30 67.28 21.36 5.29
2018-06-30 68.44 25.00 4.92
2018-03-31 58.78 17.90 3.76
2017-12-31 53.10 16.44 2.62
2017-09-30 31.89 14.62 2.15
2017-06-30 27.26 10.77 1.97
2017-03-31 31.73 12.71 1.95
2016-12-31 28.78 8.22 2.01
2016-09-30 23.42 6.23 1.39
2016-06-30 20.20 4.74 1.13
2016-03-31 16.63 4.05 0.98
2015-12-31 13.62 3.66 0.80
2015-09-30 12.09 4.24 0.89
2015-06-30 7.71 1.83 1.27
2015-03-31 4.58 1.55 1.82
2014-12-31 4.61 1.48 1.73
2014-09-30 3.64 1.29 1.81
2014-06-30 3.87 1.70 1.75
2014-03-31 2.80 1.32 1.12
2013-12-31 2.21 0.80 1.25
2013-09-30 1.52 0.01 0.89
2013-06-30 1.03 0.08 0.79
2013-03-31 0.80 0.11 0.68
2012-12-31 0.73 0.08 0.43

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Whilst Kancelaria Medius has efficiently used shareholders’ funds last year (Return on Equity greater than 20%), this is metric is skewed due to its high level of debt.
  • Kancelaria Medius used its assets more efficiently than the PL Commercial Services industry average last year based on Return on Assets.
  • Kancelaria Medius has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Kancelaria Medius's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Commercial Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Kancelaria Medius has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

KME Health

 How is Kancelaria Medius's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Kancelaria Medius's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Kancelaria Medius is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Kancelaria Medius's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Kancelaria Medius's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Kancelaria Medius Company Filings, last reported 2 months ago.

WSE:KME Past Debt and Equity Data
Date (Data in PLN Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 63.20 101.05 11.60
2018-09-30 62.55 101.55 6.71
2018-06-30 59.28 104.12 8.03
2018-03-31 65.73 108.83 30.53
2017-12-31 41.62 74.32 143.71
2017-09-30 37.63 56.75 100.12
2017-06-30 31.06 42.57 73.55
2017-03-31 27.82 40.10 70.72
2016-12-31 25.31 36.65 67.18
2016-09-30 22.96 30.94 49.58
2016-06-30 20.33 18.71 38.14
2016-03-31 17.14 19.08 34.09
2015-12-31 16.14 12.51 28.17
2015-09-30 9.42 11.40 17.23
2015-06-30 6.84 11.37 14.78
2015-03-31 6.73 7.99 10.50
2014-12-31 6.08 5.45 7.90
2014-09-30 4.48 5.83 17.46
2014-06-30 4.24 3.56 11.49
2014-03-31 4.12 2.51 8.23
2013-12-31 4.64 2.41 2.55
2013-09-30 3.92 0.41 4.01
2013-06-30
2013-03-31
2012-12-31 2.59 0.02 0.16
  • Kancelaria Medius's level of debt (159.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (52% vs 159.9% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 5.4x coverage).
X
Financial health checks
We assess Kancelaria Medius's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Kancelaria Medius has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

KME Dividends

 What is Kancelaria Medius's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Kancelaria Medius dividends.
If you bought PLN2,000 of Kancelaria Medius shares you are expected to receive PLN0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Kancelaria Medius's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Kancelaria Medius's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WSE:KME Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Commercial Services Industry Average Dividend Yield Market Cap Weighted Average of 76 Stocks 3.1%
Poland Market Average Dividend Yield Market Cap Weighted Average of 207 Stocks 3.3%
Poland Minimum Threshold Dividend Yield 10th Percentile 1.4%
Poland Bottom 25% Dividend Yield 25th Percentile 2.6%
Poland Top 25% Dividend Yield 75th Percentile 7.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Kancelaria Medius has not reported any payouts.
  • Unable to verify if Kancelaria Medius's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Kancelaria Medius's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Kancelaria Medius has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Kancelaria Medius's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.4%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Kancelaria Medius afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Kancelaria Medius has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

KME Management

 What is the CEO of Kancelaria Medius's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Michal Imiolek
CEO Bio

Mr. Michal Imiolek serves as the President of the Management Board at Kancelaria Medius S.A.

CEO Compensation
  • Insufficient data for Michal to compare compensation growth.
  • Insufficient data for Michal to establish whether their remuneration is reasonable compared to companies of similar size in Poland.
Management Team

Michal Imiolek

TITLE
President of the Management Board
Board of Directors

Artur Bienkowski

TITLE
Chairman of the Supervisory Board

Marcin Rymaszewski

TITLE
Member of the Supervisory Board

Aleksander Szalecki

TITLE
Member of the Supervisory Board

Przemyslaw Kowalewski

TITLE
Member of Supervisory Board

Dominik Majewski

TITLE
Member of Supervisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (PLN) Value (PLN)
X
Management checks
We assess Kancelaria Medius's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Kancelaria Medius has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

KME News

Simply Wall St News

Did You Miss Kancelaria Medius's Magnificent 1591% Share Price Gain?

And highest quality companies can see their share prices grow by huge amounts. … (WSE:KME) share price is up a whopping 1591% in the last half decade, a handsome return for long term holders. … Over half a decade, Kancelaria Medius managed to grow its earnings per share at 69% a year.

Simply Wall St -

Does Kancelaria Medius S.A. (WSE:KME) Have A Good P/E Ratio?

To keep it practical, we'll show how Kancelaria Medius S.A.'s (WSE:KME) P/E ratio could help you assess the value on offer. … Kancelaria Medius has a P/E ratio of 6.35, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

A Closer Look At Kancelaria Medius S.A.'s (WSE:KME) Impressive ROE

By way of learning-by-doing, we'll look at ROE to gain a better understanding of Kancelaria Medius S.A. … Kancelaria Medius has a ROE of 34%, based on the last twelve months. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Understanding Your Return On Investment In Kancelaria Medius SA (WSE:KME)

and want to begin learning the link between Kancelaria Medius SA (WSE:KME)’s return fundamentals and stock market performance. … Kancelaria Medius stock represents an ownership share in the company. … Thus, to understand how your money can grow by investing in Kancelaria Medius, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)

Simply Wall St -

How Did Kancelaria Medius SA's (WSE:KME) 27.2% ROE Fare Against The Industry?

The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want to begin learning the link between company’s fundamentals and stock market performance. … But ROE does not capture any debt, so we only see high profits and low equity, which is great on the surface.

Simply Wall St -

Should You Be Concerned About Kancelaria Medius SA's (WSE:KME) Earnings Growth?

After reading Kancelaria Medius SA's (WSE:KME) most recent earnings announcement (31 March 2018), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … Could KME beat the long-term trend and outperform its industry. … KME's trailing twelve-month earnings (from 31 March 2018) of zł17.90m has

Simply Wall St -

Should You Sell Kancelaria Medius SA (WSE:KME) At This PE Ratio?

This article is intended for those of you who are at the beginning of your investing journey. … and want to better understand how you can grow your money by investing in Kancelaria Medius SA (WSE:KME). … Kancelaria Medius SA (WSE:KME) is currently trading at a trailing P/E of 20.7x, which is higher than the industry average of 12.3x.

Simply Wall St -

KME Company Info

Description

Kancelaria Medius S.A. engages in the receivables management business in Poland. It offers debt portfolios purchasing, debt collection management, and legal services, as well as manages claims secured by a mortgage. The company is headquartered in Kraków, Poland.

Details
Name: Kancelaria Medius S.A.
KME
Exchange: WSE
Founded:
PLN132,694,607
14,581,825
Website: http://www.kancelariamedius.pl
Address: Kancelaria Medius S.A.
ul. Babinskiego 69,
Kraków,
30-393,
Poland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
WSE KME Common Bearer Shares Warsaw Stock Exchange PL PLN 06. Aug 2012
Number of employees
Current staff
Staff numbers
0
Kancelaria Medius employees.
Industry
Diversified Support Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/03/20 21:41
End of day share price update: 2019/03/20 00:00
Last earnings filing: 2019/02/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.